The potential role of topically applied heparan sulfate in the treatment of photodamage

Journal of Drugs in Dermatology

Volumn 14, Issue 7, 2015, Pages 669-674

  Gallo, Richard L ^h   Bucay, Vivian W ^a   Shamban, Ava T ^b   Lima Maribona, Janice ^c   Lewis, Amy B ^d   Ditre, Cherie M ^e   Mayoral, Flor A ^f   Gold, Michael H ^g  

^a Bucay Center for Dermatology and Aesthetics   (United States)

^b AVA MD   (United States)

^c Bay Pointe Dermatology and Cosmetics   (United States)

^d Amy B Lewis Dermatology   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f Mayoral Dermatology   (United States)

^g GOLD SKIN CARE CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; HEPARAN SULFATE; PROTEOGLYCAN; DERMATOLOGICAL AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; DRUG FORMULATION; ELASTICITY; FEMALE; HUMAN; HYDRATION; LIGHT DAMAGE; MIDDLE AGED; SKIN REDNESS; TREATMENT DURATION; WOUND HEALING; WRINKLE; CUTANEOUS PARAMETERS; DRUG EFFECTS; INTRADERMAL DRUG ADMINISTRATION; RADIATION RESPONSE; SKIN;

ADMINISTRATION, CUTANEOUS; DERMATOLOGIC AGENTS; HEPARITIN SULFATE; HUMANS; SKIN; SKIN AGING;

EID: 84955641937     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Gallo RL, Trowbridge JM. Proteoglycans and glycosaminoglycans of skin. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF Goldsmith LA, Katz SI, eds. Fitz- patrick's Dermatology in General Medicine. 6th ed. New York, NY: McGraw-Hill. 2003:210-216
2. Gallo RL. Proteoglycans and cutaneous vascular defense and repair. J Investig Dermatol Symp Proc. 2000:5:55-60.
3. Beer K. A randomized, evaluator-blinded comparison of efficacy of hyaluronic acid gel and avian-sourced hylan B plus gel for correction of nasolabial folds. Dermatol Surg. 2007;33:928-936.
4. Prathiba V., Gupta PD. Cutaneous wound healing: significance of PGs in scar formation. Current Science. 2000;78:1-5.
5. Kjellén L, Lindahl U. Proteoglycans: structures and interactions. Annu Rev Bio- chem. 1991;60:443-475.
6. Gallo R, Kim C, Kokenyesi R, et al. Syndecans-1 and -4 are induced during wound repair of neonatal but not fetal skin. J Invest Dermatol. 1996;107:676-683.
7. Noonan DM, Fulle A, Valente R et al. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J Biol Chem. 1991;266:22939-22947.
8. lozzo RV, Murdoch AD. Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J. 1996;10:598-614.
9. Oksala O, Salo T ,Tammi R, et al. Expression of proteoglycans and hyaluronan during wound healing, J Histochem Cytochem. 1995;43:125-135.
10. Wu J, Utani A, Endo H, Shinkai H. Deficiency of the decorin core protein in the variant form of Ehlers-Danlos syndrome with chronic skin ulcer. J Dermatol Sci. 2001;27:95-103.
11. Passi A, Albertini R, Baccarani Contri M, et al. Proteoglycan alterations in skin fibroblast cultures from patients affected with pseudoxanthoma elasticum. Cell Biochem Fund. 1996;14:111-120.
12. Kuroda K, Shinkai H. Decorin and glycosaminoglycan synthesis in skin fibroblasts from patients with systemic sclerosis. Arch Dermatol Res. 1997;289:481- 485.
13. Seyger MM., van den Born J, Schalkwijk J, et al. Altered distribution of heparan sulfate proteoglycans in psoriasis. Acta Derm Venereol. 1997;77:105-109.
14. Turakainen H, Valimaki M, Penttinen R. Synthesis of collagen in skin fibroblasts cultured from a patient with lichen myxedematosus. Arch Dermatol Res. 1985:277:55-59.
15. Margelin D, Fourtanier A., Thevenin T et al. Alterations of proteoglycans in ultravi- olet-irradiated skin. Photochem Photobiol. 1993;58:211-218.
16. Lundqvist K, Schmidtchen A. Immunohistochemical studies on proteoglycan expression in normal skin and chronic ulcers. Br J Dermatol. 2001;144:254-259.
17. Brakman M, StarinkTM, Tafelkruyer J, Bos JD. Linear connective tissue naevus of the proteoglycan type ('naevus mucinosus'). Br J Dermatol. 1994:131:368- 370.
18. Edward M. Proteoglycans and glycosaminoglycans. In: Priestley, GC, ed. Molecular Aspects of Dermatology. Chichester, England: John Wiley & Sons. 1993:89-110.
19. Maata A, Jaakkola P, Jalkanen M. Extracellular matrix-dependent activation of syndecan-1 expression in keratinocyte growth factor-treated keratinocytes. J Biol Chem. 1999;274: 9891-9898.
20. Stepp MA, Pal-Ghosh S, Tadvalkar G, et al. Loss of syndecan-1 is associated with malignant conversion in skin carcinogenesis. Mol Carcinog. 2010;49:363- 373.
21. Bishop JR, Schuksz M, Esko JD. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature. 2007;446:1030-1037.
22. Thompson LD, Pantoliano MW, Springer BA. Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain. Biochemistry. 1994;33:3831-3840.
23. Stringer SE, Gallagher JT Heparan sulphate. Int J Biochem Cell Biol. 1997;29:709-714.
24. Polieri T, Orsoni E, Saponati G., Castellacci E. Efficacy and tolerability of Cla- rema 1% Cream and Hirudoid 40000 U.APTT Gel in the topical treatment of haematomas and/or subcutaneous haematic extravasations, ISRN Orthopedics. 2012;2012:Article ID 504151. 5 pages.
25. Gallo RL, Ono M., Povsic T et al. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc Natl Acad Sci USA. 1994;91:11035-11039.
26. Meddahi A, Caruelle Jr. Gold L, et al. New concepts in tissue repair: skin as an example. Diabetes Metab. 1996;22:274-278.
27. Andriessen MP, van den Born J, Latijnhouwers MA, et al. Basal membrane heparan sulphate proteoglycan expression during wound healing in human skin. J Pathol. 1997; 183:264-271.
28. McGrath JA, Eady RA Heparan sulphate proteoglycan and wound healing in skin. J Pathol. 1997;183:251-252.
29. Fears CY, Woods A.The role of syndecans in disease and wound healing. Matrix Biol. 2006; 25:443-456.
30. Alexopoulou AN, Multhaupt HA, Couchman JR. Syndecans in wound healing, inflammation and vascular biology. Int J Biochem Cell Biol. 2007;39:505-528.
31. Tong M, Tuk B, Shang R et al. Diabetes-impaired wound healing is improved by matrix therapy with heparan sulfate glycosaminoglycan mimetic OTR4120 in rats. Diabetes. 2012; 61:2633-2641.
32. Maltseva I, Chan M, Kalus I, et al. The SULFs, extracellular sulfatases for heparan sulfate, promote the migration of corneal epithelial cells during wound repair. PLoS One. 2013;8:e69642.
33. Martino MM, Briquez PS, Gug E, et al. Growth factors engineered for super- Affinity to the extracellular matrix enhance tissue healing. Science. 2014; 343(6173):885-888.
34. Gheduzzi D., Guerra D, Bochicchio B, et al. Heparan sulphate interacts with tropoelastin. with some tropoelastin peptides and is present in human dermis elastic fibers. Matrix Biol. 2005; 24:15-25.
35. Garcia-Filipe S1, Barbier-Chassefiere V, Alexakis C et al. RGTA OTR4120C a heparan sulfate mimetic, is a possible long-term active agent to heal burned skin, J Biomed Mater Res A. 2007;80:75-84.
36. van Neck J, Tuk B, Barritault D, MiaoTong M. (2012). Heparan sulfate proteoglycan mimetics promote tissue regeneration: An overview, tissue regeneration - from basic biology to clinicalapplication, Prof. Jamie Davies (Ed.), ISBN: 978-953-51-0387-5, InTech, Available from: http://www.intechopen.com/books/tissue-regeneration-from-basic-biology-to-clinical-application/heparansulfate-proteoglycan-mimetics-thrive-tissue-regeneration-an-overview. Accessed February 23, 2015.
37. DePrisco G., Bandel C, Cockerell CJ, EhrigT. Interstitial heparan sulfate in granulomatous inflammatory skin diseases. J Am Acad Dermatol. 2004;50:253-257.
38. Taylor KR, Gallo RL. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J. 2006;20:9-22.
39. Gilchrest BA, Stoff JS, Soter NA. Chronologic aging alters the response to ultraviolet-induced inflammation in human skin. J Invest Dermatol. 1982;79:11-15.